Copertina

Targeting the NSUN5-circPPAP2A axis reverses immunosuppression and sensitizes renal cell carcinoma to anti-PD-1 therapy

Fuente: Zenodo

Salvato in:

Dettagli Bibliografici
Autore principale:	First Affiliated Hospital of Guangzhou Medical University
Natura:	Recurso digital
Pubblicazione:	Zenodo 2026
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

High-resolution single-cell atlas reveals distinct immune microenvironments in EGFR-mutant versus wild-type lung adenocarcinoma
di: Tianjin Medical University Cancer Institute and Hospital
Pubblicazione: (2025)

date
di: Tianjin Medical University Eye Hospital
Pubblicazione: (2026)

Obesity enhances the response to neoadjuvant anti‐ PD1 therapy in oral tongue squamous cell carcinoma
di: Xiyan Tan, et al.
Pubblicazione: (2024)

CircRNome‐wide characterisation reveals the promoting role of circAATF in anti‐PD‐L1 immunotherapy of gallbladder carcinoma
di: Yueqi Wang, et al.
Pubblicazione: (2024)

МЕДИЦИНСКИЙ ГЕЛИОАППАРАТ ДЛЯ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ ПРОСТУДНЫХ ЗАБОЛЕВАНИЙ
di: Central Asian Medical University
Pubblicazione: (2024)

circ_0000592 facilitates the progression of esophageal squamous cell carcinoma via miR‐155‐5p/FZD5 axis
di: Jinxian He, et al.
Pubblicazione: (2024)

Potential targets for renal cell carcinoma therapy: Mechanistic research and prospects of CAFs in renal cell carcinoma
di: Ruiqiang Sun, et al.
Pubblicazione: (2026)

CHD6 drives an immunosuppressive vascular ecotype and therapy resistance in hepatocellular carcinoma
di: Fan, Xutong, et al.
Pubblicazione: (2026)

Erratum to “The miR ‐140‐5p/ KLF9 / KCNQ1 axis promotes the progression of renal cell carcinoma”
Pubblicazione: (2024)

Correction to “Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD‐L1)‐mediated immunosuppression”
Pubblicazione: (2024)

GHITM regulates malignant phenotype and sensitivity to PD‐1 blockade of renal cancer cells via Notch signalling
di: Shiyu Huang, et al.
Pubblicazione: (2024)

Utilization of immunosuppressants by people with renal transplant
di: Bianca Pozza dos Santos
Pubblicazione: (2017)

Amentoflavone reverses epithelial‐mesenchymal transition in hepatocellular carcinoma cells by targeting p53 signalling pathway axis
di: Hui‐Ying Jian, et al.
Pubblicazione: (2024)

Obesity correlates with the immunosuppressive ILC2s‐MDSCs axis in advanced breast cancer
di: Wei Liu, et al.
Pubblicazione: (2024)

Efficacy of anti‐PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA
di: Amira Marouf, et al.
Pubblicazione: (2025)

Single‐cell transcriptomic analysis reveals that the APP–CD74 axis promotes immunosuppression and progression of testicular tumors
di: Guo Chen, et al.
Pubblicazione: (2024)

Metabolic Recoding of NSUN2‐Mediated m5C Modification Promotes the Progression of Colorectal Cancer via the NSUN2/YBX1/m5C‐ENO1 Positive Feedback Loop
di: Baoxiang Chen, et al.
Pubblicazione: (2024)

Association Analysis of BRCA1 , PPAP2B , and KCNN3 Gene Polymorphisms With Litter Size in Sheep
di: Yu He, et al.
Pubblicazione: (2025)

Effects of electromagnetic pulses, exosomes inhibition and their coaction on A549 cells
di: Qian Zhang, et al.
Pubblicazione: (2024)

Astragaloside IV regulates circ_0001615 and miR‐873‐5p/LASP1 axis to suppress colorectal cancer cell progression
di: Pengfei Kong, et al.
Pubblicazione: (2024)

Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
di: Shiqi Li, et al.
Pubblicazione: (2024)

Identification of a stable immunosuppressive molecular subtype in esophageal squamous cell carcinoma based on inflammation‐related genes
di: Yuan Yin, et al.
Pubblicazione: (2024)

Paper 11 - Structural Operating Framework for the AI+AGI Era
di: The First Waters
Pubblicazione: (2026)

Institutional Foundations of Ukrainian Democracy: Power Sharing, Regionalism, and Authoritarianism by NataliyaKibita. Oxford: Oxford University Press, 2024. 400 pp. $155.00. ISBN 978‐0‐19‐289881‐4
di: Joshua First
Pubblicazione: (2025)

5` 10x Genomics single cell RNA sequencing of CD4+ T cells from PI3K GOF and WT mice
di: Deenick, Elissa, et al.
Pubblicazione: (2025)

Dynamic signature for the effectiveness of anti–PD‐1 therapy combined with vascular normalization therapy in recurrent glioblastoma: A randomized phase 2 trial
di: Jiubing Zhang, et al.
Pubblicazione: (2026)

2‐Undecanone induces ferroptosis via the STAT3/GPX4 pathway to enhance sensitivity of renal cell carcinoma to sunitinib
di: Zixuan Chen, et al.
Pubblicazione: (2025)

The clinicopathological significance and prognostic value of PD‐L1 in oral squamous cell carcinoma
di: Yizhan Li, et al.
Pubblicazione: (2024)

SCARB1‐encoded circ _0029343 induces p73 splicing to promote growth and metastasis of hepatocellular carcinoma via miR‐486‐5p/SRSF3 axis
di: Shuo Zhu, et al.
Pubblicazione: (2024)

NSUN2 ‐mediated m 5 C methylation modification regulates trophoblast cell proliferation, apoptosis, and autophagy in gestational diabetes mellitus
di: Jiujiu Liu, et al.
Pubblicazione: (2025)

RNA Methyltransferase NSUN5 Promotes Esophageal Cancer via 5‐Methylcytosine Modification of METTL1
di: Yuanbo Cui, et al.
Pubblicazione: (2024)

Early immunosuppression therapy improves outcomes in CD8+ T‐cell activated paediatric acute liver failure and hepatitis
di: Prerna Diksha, et al.
Pubblicazione: (2026)

Comprehensive analyses of nuclear mitochondria‐related genes in the molecular features, immune infiltration, and drug sensitivity of clear cell renal cell carcinoma
di: Yuchen Zhang, et al.
Pubblicazione: (2024)

Treatment of progressive locally advanced and metastatic basal cell carcinoma after two lines of treatment with hedgehog inhibitors and anti‐PD1: The role of sonidegib rechallenge
di: L. Ambrosio, et al.
Pubblicazione: (2025)

flow cytometry data of renal cell carcinoma
di: jiawei, chen
Pubblicazione: (2026)

Solitary pancreatic renal cell carcinoma metastasis
di: Miguel Nogueira
Pubblicazione: (2018)

NSUN5 Facilitates Hepatocellular Carcinoma Progression by Increasing SMAD3 Expression
di: Hexu Han, et al.
Pubblicazione: (2024)

Acanthosis Nigricans associated with clear-cell renal cell carcinoma
di: Fernando Peixoto Ferraz de Campos
Pubblicazione: (2016)

Quantitative cancer-immunity cycle modeling to optimize bevacizumab and atezolizumab combination therapy for advanced renal cell carcinoma
di: Du, Lei, et al.
Pubblicazione: (2026)

Host ANGPTL2 establishes an immunosuppressive tumor microenvironment and resistance to immune checkpoint therapy
di: Shinsei Yumoto, et al.
Pubblicazione: (2024)